Latest Industry News & Trends

Market Scope provides comprehensive coverage of the ophthalmic and orthopedic markets. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with companies executive. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic or orthopedic industry newsletters.

Recently Added

Murray Takes Over Centinel Spine CEO Position After Viscogliosi

Centinel Spine’s new CEO, Steven Murray, comes from his role as President of Advanced Sterilization Products and Johnson & Johnson; he was previously the president of Synthes Spine. John Viscoglios...

Study Indicates That Dual-Mobility Hip Implants Used for Revision May Have Fewer Complications

The Journal of Arthroplasty published a study comparing revisions of metal-on-metal THA using either a dual-mobility implant or complete revision of the acetabular component. Revisions were primari...

Zimmer Biomet Issues Field Safety Notice for Some StageOne and StageOne Select Molds

Zimmer Biomet announced March 17 that, due to potential insufficient cleaning and monitoring of StageOne and StageOne Select bone cement molds, it is issuing a field safety notice. Of 230 thousand ...

Acumed Enters Distribution Agreement With Vivorte

Acumed will become the exclusive distributer or Vivorte’s orthobiologics portfolio. The agreement, announced March 13, will give Vivorte access to Acumed’s sales, marketing, and medical education e...

Ortho RTI’s Rotator Cuff Tear Product Achieves Positive Results

Positive results from a preclinical study of Ortho Regenerative Technologies Inc.’s (Ortho RTI) rotator cuff tear repair product, Ortho-R, were announced March 12. The preclinical ovine work showed...

DePuy Synthes Receives CE Mark for Dual-Mobility Hip

DePuy Synthes received CE marking for its Bi-Mentum dual-mobility hip, the company announced March 12. The device is intended for patients at risk for dislocation to reduce the need for additional ...

BreakingCOVID 19MeetingOphthalmic
Market Scope Lists 2020 Ophthalmic Meetings Canceled, Delayed Due to COVID-19

Market Scope is tracking the status of 2020 ophthalmic meetings worldwide as the COVID-19 outbreak spreads. Several conferences have been delayed or canceled outright. Here is the latest informatio...

BreakingCOVID 19DiagnosticOphthalmicRetina
COVID-19 Update: MDR Delay Coming?; Glaucoma Meeting Postponed; Companies Join Pandemic Fight

The European Commission (EC) is working on a proposal to delay enforcement of the EU Medical Device Regulation by a year, a spokesperson said March 25. Policymakers hope to submit the proposal in e...

Surgeon, LinkoCare Developing Corneal Inlay Made of Biosynthetic Collagen

Pavel Stodulka, MD, PhD, of the Czech Republic, is working with Swedish companyLinkoCare to develop a corneal reshaping inlay made of biosynthetic collagen to correct presbyopia. The inlay candidat...

BreakingDeviceLow VisionOphthalmicRegulation
Second Sight Gains CE Marking, US Conditional Approval for Wearables to be Tested with Orion

Second Sight announced March 19 that it had gained CE marking and US conditional approval for its next-generation wearables with the Argus II retinal prosthesis that include a more powerful video p...

Ribomic Licenses Wet AMD Candidate to Aju Pharm

Tokyo-based Ribomic reported March 17 that it had licensed to Aju Pharm a retinal candidate (RBM-007) for wet age-related macular degeneration (wet AMD) in Korea and Southeast Asia. Aju, of South K...

Iveric bio Appoints Dugel as Executive Vice President and Chief Strategy and Business Officer

Iveric bio announced March 23 that leading retina specialist Pravin Dugel, MD, would be appointed executive vice president and chief strategy and business officer, effective April 1. The New York c...

Past News Stories

BreakingDeviceLow VisionOphthalmic
McGuire Steps Down as CEO of Second Sight; Chairman Williams Takes Over as Interim Chief

Second Sight Medical Products CEO Will McGuire is leaving the company to accept a similar role at Ra Medical, a Carlsbad, California, medical device company focusing on commercializing excimer lase...

Lenstec Submits PMA Application to FDA for SBL-3 Segmented Bifocal Lens

Lenstec announced March 16 that had submitted a premarket approval application to the US FDA for its SBL-3 presbyopia-correcting intraocular lens (PC-IOL). The SBL-3 would be the first segmented bi...

BreakingDealsGene TherapyOphthalmicRetina
Horama Licenses Retinal Gene Therapy Candidate from Leiden University

French ophthalmic gene therapy company Horama announced March 18 that it licensed from Leiden University Medical Center an adeno-associated viral (AAV) gene therapy program to treat inherited retin...

BreakingClinical TrialOphthalmicPharmaRetina
Graybug Ends Phase IIb Enrollment Early After Confirming Dosing Regimen

Graybug Vision announced March 18 that it had closed enrollment early in its Phase IIb trial of GB-102 (1 or 2 mg) in wet age-related macular degeneration (AMD), because the company intends to move...

Eyenovia Raises $5.3 Million in Private Placement for Microdose Candidates

Eyenovia reported March 25 that it raised $5.3 million in net proceeds in a private placement of units made up of common stock and warrants. The company said it intends to use the proceeds, togethe...

BreakingCOVID 19DiagnosticEarningsMeetingOphthalmic
COVID-19 Update: OCTANe Summit, AAPOS Meeting, Industry Announcements

OCTANe has moved its Ophthalmology Technology Summit to July 31 from June 26 due to the pandemic, the group announced on its website. The Fashion Island Hotel in Newport Beach, California, remains ...

RSIP Vision Releases 3D Knee Reconstruction Technology That Uses Radiographs

RSIP Vision announced March 16 that its AI-based 3D reconstruction solution for knees is available. The technology takes pre-op X-rays and converts them into 3D anatomical models that can be used t...

CMS Proposes the Addition of Outpatient THA and TKA to Bundled Payment Plan

CMS published a proposed rule on March 5, suggesting that outpatient knee and hip replacement surgeries (TKA and THA, respectively) be added to the Comprehensive Care for Joint Replacement (CJR) Mo...

FDA Releases Third-Party Reviewer Guidelines

The FDA announced March 12 that it has released guidance for the 510(k) Third-Party Review Program, also known as 3P510k Review Program. Qualified third-party programs review premarket notification...

Study Shows Post-Traumatic Arthritis Has Larger Impact on TKA Complications Than OA

A study by Brockman et al., published in the Journal of Arthroplasty in Feb., compared TKA outcomes for 14,206 patients with post-traumatic arthritis and 1,287,188 patients with osteoarthritis (OA)...

Patients Will Have Access to Personal Health Data Under New HHS Rules

The HHS and CMS finalized two new rules, announced March 10, that will require providers to give secure, free access to health information for patients. Under the new rules, patients will be able t...

FDA Publishes Final Guidance for Bone Anchors

On March 7, the FDA released its final guidance for bone anchor 510(k) submissions. The guidelines include necessary submission requirements and recommended methods for bench testing. Specifically,...

Want to Read the Full Article?

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.

Select one or more
Select one or more

Market Scope

13421 Manchester Road, Suite 201 | St. Louis, MO 63131 | Phone: 314-835-0600 | Email:

©2020 Market Scope, LLC. All Rights reserved.